药品生产企业责任的法律基础

I. Barinova
{"title":"药品生产企业责任的法律基础","authors":"I. Barinova","doi":"10.18572/1812-3929-2023-2-62-66","DOIUrl":null,"url":null,"abstract":"The author compares the concepts of ‘”circulation of medicines” and “pharmaceutical activity”. The main content of the text is an analysis of the responsibility of manufacturers for damage caused to the health of citizens by substandard, falsified medicines. The relevance lies in the fact that now, during the pandemic, special attention is being paid to new medicines. Due to the fact that they are a special type of product, they are subject to strict requirements for quality, safety and effectiveness, compliance with which also falls on manufacturers of medicines, which once again underlines the need for clearly defined responsibility of manufacturers of medicines. In conclusion, the author suggests possible changes in the legislation on the responsibility of the manufacturer of medicines.","PeriodicalId":81750,"journal":{"name":"Jurist (Washington, D.C.)","volume":"21 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Legal Fundamentals of Liability of Medicinal Products Manufacturers\",\"authors\":\"I. Barinova\",\"doi\":\"10.18572/1812-3929-2023-2-62-66\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The author compares the concepts of ‘”circulation of medicines” and “pharmaceutical activity”. The main content of the text is an analysis of the responsibility of manufacturers for damage caused to the health of citizens by substandard, falsified medicines. The relevance lies in the fact that now, during the pandemic, special attention is being paid to new medicines. Due to the fact that they are a special type of product, they are subject to strict requirements for quality, safety and effectiveness, compliance with which also falls on manufacturers of medicines, which once again underlines the need for clearly defined responsibility of manufacturers of medicines. In conclusion, the author suggests possible changes in the legislation on the responsibility of the manufacturer of medicines.\",\"PeriodicalId\":81750,\"journal\":{\"name\":\"Jurist (Washington, D.C.)\",\"volume\":\"21 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-02-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Jurist (Washington, D.C.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18572/1812-3929-2023-2-62-66\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurist (Washington, D.C.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18572/1812-3929-2023-2-62-66","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

笔者对“药品流通”和“药品活动”的概念进行了比较。本文的主要内容是分析生产企业对伪劣药品对公民健康造成损害的责任。其相关性在于,现在,在大流行病期间,对新药给予了特别关注。由于它们是一种特殊类型的产品,它们在质量、安全性和有效性方面受到严格的要求,药品制造商也必须遵守这些要求,这再次强调了药品制造商明确界定责任的必要性。总之,作者建议在药品制造商的责任立法中可能发生的变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Legal Fundamentals of Liability of Medicinal Products Manufacturers
The author compares the concepts of ‘”circulation of medicines” and “pharmaceutical activity”. The main content of the text is an analysis of the responsibility of manufacturers for damage caused to the health of citizens by substandard, falsified medicines. The relevance lies in the fact that now, during the pandemic, special attention is being paid to new medicines. Due to the fact that they are a special type of product, they are subject to strict requirements for quality, safety and effectiveness, compliance with which also falls on manufacturers of medicines, which once again underlines the need for clearly defined responsibility of manufacturers of medicines. In conclusion, the author suggests possible changes in the legislation on the responsibility of the manufacturer of medicines.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信